Log In
BCIQ
Print this Print this
 

HBV mAb

  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
DescriptionHBV neutralizing human mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat hepatitis B virus (HBV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today